Centene
About: Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Employees: 60,500
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
40% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 87
2% more funds holding
Funds holding: 860 [Q4 2024] → 878 (+18) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 12 [Q4 2024] → 12 (+0) [Q1 2025]
1% less repeat investments, than reductions
Existing positions increased: 320 | Existing positions reduced: 323
4% less capital invested
Capital invested by funds: $29.1B [Q4 2024] → $27.8B (-$1.27B) [Q1 2025]
2.56% less ownership
Funds ownership: 95.01% [Q4 2024] → 92.45% (-2.56%) [Q1 2025]
35% less call options, than puts
Call options by funds: $183M | Put options by funds: $281M
Research analyst outlook
12 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$28
10%
upside
Avg. target
$35
36%
upside
High target
$45
76%
upside
12 analyst ratings
2 positive
17%
9 neutral
75%
1 negative
8%
JP Morgan John Stansel | 18%upside $30 | Neutral Maintained | 29 Jul 2025 |
UBS A.J. Rice | 21%upside $31 | Neutral Maintained | 28 Jul 2025 |
Truist Securities Ryan MacDonald | 37%upside $35 | Buy Maintained | 28 Jul 2025 |
Oppenheimer Michael Wiederhorn | 68%upside $43 | Outperform Maintained | 28 Jul 2025 |
Cantor Fitzgerald Sarah James | 49%upside $38 | Neutral Downgraded | 28 Jul 2025 |
Financial journalist opinion
Based on 179 articles about CNC published over the past 30 days
Neutral
PRNewsWire
19 hours ago
Centene Corporation (CNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES , July 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Centene Corporation ("Centene" or the "Company") (NYSE: CNC). IF YOU SUFFERED A LOSS ON YOUR CENTENE INVESTMENTS, CLICK HERE BEFORE SEPTEMBER 8, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
Neutral
PRNewsWire
21 hours ago
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Centene To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Centene between December 12, 2024 and June 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Centene Corporation ("Centene" or the "Company") (NYSE: CNC) and reminds investors of the September 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Neutral
PRNewsWire
22 hours ago
eHealth Announces CEO Succession
Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas , July 29, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4 th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025.
Neutral
PRNewsWire
23 hours ago
Levi & Korsinsky Reminds Centene Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 8, 2025 - CNC
NEW YORK , July 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Centene investors who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025.
Positive
Seeking Alpha
1 day ago
Centene: Opportunity At
Centene (CNC) is deeply undervalued, trading at a fraction of its normalized earnings potential due to temporary headwinds and sector-wide pessimism. The company's scale, low-cost leadership, and diversified business lines ensure resilience, with historical profit margins likely to revert as one-off distortions fade. Long-term tailwinds include demographic-driven Medicaid/Medicare growth, technology-driven efficiency gains, and the high-potential ICHRA business.
Neutral
GlobeNewsWire
1 day ago
Investors in Centene Corporation Should Contact Levi & Korsinsky Before September 8, 2025 to Discuss Your Rights – CNC
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.
Neutral
GlobeNewsWire
1 day ago
Centene Corporation (CNC) Shares Fall ~10% Pre-Market After Reporting Q2 2025 Diluted Loss Per Share, Class Action Lawsuit Over “Inflated Guidance” Pending – Hagens Berman
SAN FRANCISCO, July 28, 2025 (GLOBE NEWSWIRE) -- Before the markets opened on July 25, 2025, investors in Centene Corporation (NYSE: CNC) saw the price of their shares decline about 10% in pre-market trading after the company reported disastrous Q2 2025 financial results.
Neutral
PRNewsWire
1 day ago
Superior HealthPlan and Centene Foundation Announce Grand Opening of CHDI Multi-Purpose Community Health Center in Uvalde
The $16 million center is managed by Community Health Development, Inc., and offers healthcare services, community support, and other resources UVALDE, Texas , July 28, 2025 /PRNewswire/ -- Superior HealthPlan and the Centene Foundation, the philanthropic arm of Centene (NYSE: CNC), today joined Community Health Development, Inc. (CHDI) to open a new $16 million multi-purpose community health center in Uvalde. The 16,000-square-foot space provides healthcare services, community support and outreach, education and workforce development, and a meeting space for the Uvalde community and the surrounding region.
Positive
Seeking Alpha
1 day ago
Centene's Bottom May Already Be Here - Risk Mitigation In Process
CNC has offered FY2025 adj EPS range at between $1.25 (-82.5% YoY) and $1.75 (-75.5% YoY), as medical costs rise drastically and higher morbidity sign-ups replace a healthier base. These have directly triggered the drastically lower consensus forward estimates, with the healthcare providers expected to report impacted, new normal profit margins. Despite so, readers must note that CNC is already engaging on risk mitigation while driving improved profitability through rate adjustments from 2026 onwards.
Neutral
GlobeNewsWire
1 day ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines - CNC
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation (“Centene” or the “Company”)(NYSE: CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Charts implemented using Lightweight Charts™